Understanding how bacteria communicate in biofilms
Elucidating mechanisms of acetylcholine signaling in bacterial biofilms
This study is looking at how a type of bacteria called Bacillus subtilis forms groups called biofilms and how they talk to each other, which could help us find better ways to treat infections that are hard to get rid of.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10899562 on NIH RePORTER |
What this research studies
This research investigates how bacteria, specifically Bacillus subtilis, form complex communities known as biofilms and how they communicate through signaling molecules like acetylcholine. By studying the genetic and metabolic pathways involved in biofilm formation, the research aims to uncover new mechanisms that contribute to antibiotic resistance and persistence in infections. The approach includes using advanced biological models to observe how these bacteria interact and share nutrients within their biofilm environment. This understanding could lead to new strategies for treating infections caused by biofilms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic infections that are difficult to treat due to biofilm formation.
Not a fit: Patients with infections that do not involve biofilm formation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for antibiotic-resistant infections caused by biofilms.
How similar studies have performed: Previous research has shown promising results in understanding bacterial communication and biofilm behavior, indicating that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Lander, Stephen — Northwestern University at Chicago
- Study coordinator: Lander, Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.